Rifabutin-induced cystoid macular oedema

Rifabutin is a semi-synthetic antimycobacterial agent mainly used in the treatment of Mycobacterium avium-complex (MAC) in AIDS patients. Rifabutin-induced anterior uveitis has been reported previously. We report the case of a rifabutin-induced cystoid macular oedema (CMO) in an immunocompetent pati...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 2002-02, Vol.49 (2), p.421-422
Main Authors: Vaudaux, J. D., Guex-Crosier, Y.
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - adverse effects
Biological and medical sciences
Drug toxicity and drugs side effects treatment
Female
Humans
Macular Edema - chemically induced
Macular Edema - diagnosis
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Pulmonary Disease, Chronic Obstructive - drug therapy
Rifabutin - adverse effects
Toxicity: eye
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rifabutin is a semi-synthetic antimycobacterial agent mainly used in the treatment of Mycobacterium avium-complex (MAC) in AIDS patients. Rifabutin-induced anterior uveitis has been reported previously. We report the case of a rifabutin-induced cystoid macular oedema (CMO) in an immunocompetent patient with pulmonary MAC infection. As far as we know, CMO secondary to rifabutin therapy has not been described previously.
ISSN:0305-7453
1460-2091
1460-2091
DOI:10.1093/jac/49.2.421